Immunotherapy

Immunotherapy refers to a form of hematology and oncology research where the body's immune system is used to fight cancer. It involves using drugs or treatments that help the immune system to recognize and attack cancer cells more effectively. The immune system is usually able to recognize and neutralize abnormal or foreign cells, including cancer cells. However, sometimes cancer cells can evade the immune system's detection or even suppress it, allowing the cancer to grow and spread. Immunotherapy works by removing the body's natural barriers to the immune system or by introducing synthetic components that boost its natural ability to detect and destroy cancer cells. This includes using monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and adoptive cell therapy. Monoclonal antibodies are targeted drugs that bind to specific proteins on cancer cells to flag them down for destruction by the immune system. Checkpoint inhibitors, on the other hand, are drugs that activate the immune system's T-cells to fight cancer by blocking the cancer's suppressive signals. Cancer vaccines work by stimulating the immune system to recognize and destroy cancer cells. These vaccines are made up of tumor-specific antigens that train the immune system to identify and attack the specific cancer cells. Finally, adoptive cell therapy is a process of using special immune cells that have been extracted, modified and reintroduced into the body to attack the cancer cells. Overall, immunotherapy holds great promise in the hematology and oncology field as a novel way to fight cancer. As research continues, it is becoming an increasingly important area in the fight against cancer.